Patton K, Borshoff DC (2018) Adverse drug reactions. Anaesthesia 73:76–84

Article  PubMed  Google Scholar 

Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 329:15–19

Article  PubMed  PubMed Central  Google Scholar 

Lim R, Kalisch Ellett LM, Semple S, Roughead EE (2022) The extent of medication-related hospital admissions in Australia: A review from 1988 to 2021. Drug Saf 45(3):249–257

Article  PubMed  PubMed Central  Google Scholar 

Roughead EE, Semple SJ, Rosenfeld E (2016) The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia. Int J Evid Based Healthc 14(3):113–122

Article  PubMed  Google Scholar 

Center for drug Evaluation aR (2018) Preventable adverse drug reactions: A focus on drug interactions. U.S. Food and Drug Administration. Available at https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse-drug-reactions-focus-drug-interactions. Accessed 12 May 2022

European Parliament (2010) Report on the proposal for a regulation of the European Parliament and of the Council amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Available at https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SEC:2008:2671:FIN:en:PDF. Accessed 12 May 2022

Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Ann Pharmacother 42:1017–1025

Article  PubMed  Google Scholar 

Miguel A, Azevedo LF, Araujo M, Pereira AC (2012) Frequency of adverse drug reactions in hospitalized patients: A systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 21(11):1139–1154

Article  PubMed  Google Scholar 

World Health Organization (2002) The importance of pharmacovigilance, safety monitoring of medicinal products. Geneva. Available at https://www.who.int/publications/i/item/10665-42493. Accessed 12 May 2022

Martin JH, Lucas C (2021) Reporting adverse drug events to the Therapeutic Goods Administration. Aust Prescr 44(1):2–3

Article  PubMed  PubMed Central  Google Scholar 

Ahmad SR (2003) Adverse drug event monitoring at the food and drug administration: Your report can make a difference. J Gen Intern Med 18:57–60

Article  PubMed  PubMed Central  Google Scholar 

Pharmacovigilance Risk Assessment Committee (PRAC) (2015) Good practice guide on recording, coding, reporting and assess-ment of medication errors. EMA/762563/2014. Available at https://www.sifoweb.it/images/pdf/attivita/attivita-scientifica/aree_scientifiche/Gestione_del_Rischio_Clinico/pdf/lg_ema_risk/Good_practice_guide_on_recording_coding_reporting_and_assessment_of_medication_errors.pdf. Accessed 15 May 2022

Inacio P, Cavaco A, Airaksinen M (2017) The value of patient reporting to the pharmacovigilance system: A systematic review. Br J Clin Pharmacol 83(2):227–246

Article  PubMed  Google Scholar 

Sienkiewicz K, Burzynska M, Rydlewska-Liszkowska I, Sienkiewicz J, Gaszynska E (2022) The importance of direct patient reporting of adverse drug reactions in the safety monitoring process. Int J Environ Res Public Health 19(413). https://doi.org/10.3390/ijerph19010413

Weigmann K (2016) Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care. EMBO Rep 17(7):949–952

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al Dweik R, Stacey D, Kohen D, Yaya S (2017) Factors affecting patient reporting of adverse drug reactions: A systematic review. Br J Clin Pharmacol 83(4):875–883

Article  PubMed  Google Scholar 

Sales I, Aljadhey H, Albogami Y, Mahmoud MA (2017) Public awareness and perception toward adverse drug reactions reporting in Riyadh. Saudi Arabia Saudi Pharm J 25(6):868–872

Article  PubMed  Google Scholar 

Kim S, Yu YM, You M, Jeong KH, Lee E (2020) A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers. BMC Public Health 20(1):1527

Article  PubMed  PubMed Central  Google Scholar 

Hariraj V, Aziz Z (2018) Patient reporting of adverse drug reactions (ADRs): Survey of public awareness and predictors of confidence to report. Ther Innov Regul Sci 52(6):757–763

Article  PubMed  Google Scholar 

Pahuja R, Shrivastava B, Sharma PK, Kishore K, Mahajan S, Sood R (2014) Awareness on adverse drug reaction reporting system in India: A consumer survey. AJPCT 2(12):1361–1369

Google Scholar 

Tejus A, Mathur AG, Vishnuprasad R, Singh A, Pradhan S (2020) An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital. Med J Armed Forces India 76(4):425–429

Article  CAS  PubMed  Google Scholar 

Fortnum H, Lee AJ, Rupnik B, Avery A (2012) Yellow card study collaboration. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. J Clin Pharm Ther 37(2):161–5

Article  CAS  PubMed  Google Scholar 

Robertson J, Newby DA (2013) Low awareness of adverse drug reaction reporting systems: A consumer survey. Med J Aust 199(10):684–686

Article  PubMed  Google Scholar 

Ribeiro-Vaz I, Silva AM, Costa Santos C, Cruz-Correia R (2016) How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis. BMC Med Inform Decis Mak 16(27). https://doi.org/10.1186/s12911-016-0265-8

Fukushima A, Iessa N, Balakrishnan MR, Pal SN (2022) Smartphone-based mobile applications for adverse drug reactions reporting: Global status and country experience. BMC Med Inform Decis Mak 22(1):118

Article  PubMed  PubMed Central  Google Scholar 

de Vries ST, Denig P, Lasheras Ruiz C, Houyez F, Wong L, Sutcliffe A et al (2018) Interest in a mobile app for two-way risk communication: A survey study among European healthcare professionals and patients. Drug Saf 41(7):697–712

Article  PubMed  PubMed Central  Google Scholar 

Qualtrics. Available at: https://www.qualtrics.com. Provo, Utah, USA. Accessed 26 Jul 2022

Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J (2012) A national census of medicines use: A 24-hour snapshot of Australians aged 50 years and older. Med J Aust 196(1):50–53

Article  PubMed  Google Scholar 

Kitabayashi A, Inoue Y (2022) Factors that lead to stagnation in direct patient reporting of adverse drug reactions: An opinion survey of the general public and physicians in Japan. Ther Innov Regul Sci 56(4):616–624

Article  PubMed  PubMed Central  Google Scholar 

van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K (2010) Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol 66(11):1143–1150

Article  PubMed  PubMed Central  Google Scholar 

de Vries ST, Denig P, Andric A, Dimov Di Giusti M, Ptaszynska-Neophytou A, Harmark L et al (2021) Motives to report adverse drug reactions to the national agency: A survey study among healthcare professionals and patients in Croatia, The Netherlands, and the UK. Drug Saf 44(10):1073–83

Article  PubMed  PubMed Central  Google Scholar 

Venkatesh V, Morris MG, Davis GB, Davis FD (2003) User acceptance of information technology: Toward a unified view. MIS Q 27(3):425–478

Article  Google Scholar 

Salgueiro E, Gurruchaga C, Jimeno FJ, Martinez-Mugica C, Martin Arias LH, Manso G (2019) What can we learn from the public’s understanding of drug information and safety? A population survey. Int J Pharm Pract 27(1):96–104

Article  PubMed  Google Scholar 

Montes-Grajales D, Garcia-Serna R, Mestres J (2023) Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events. Sci Rep 13(1):18817

Article  CAS  PubMed  PubMed Central  Google Scholar 

Australian Government; Department of Health and Aged Care; Therapeutic Goods Administration. COVID-19 vaccine: information for consumers and health professionals. Available at: https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccine-information-consumers-and-health-professionals. Published 2021. Accessed 02 Nov 2023

Valinciute A, Gerbutaviciene RJ, Paukstaitiene R, Kubiliene L (2023) Pharmacovigilance and adverse drug reaction reporting among the general public in Lithuania: a cross-sectional study. Healthcare 11(1133). https://doi.org/10.3390/healthcare11081133

Matos C, van Hunsel F, Joaquim J (2015) Are consumers ready to take part in the pharmacovigilance system?–a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol 71(7):883–890

Article  PubMed  Google Scholar 

Smith AJ, McGettigan P (2000) Quality use of medicines in the community: The Australian experience. Br J Clin Pharmacol 50:515–519

Article  CAS  PubMed  PubMed Central